期刊文献+

垂体腺苷酸环化酶激活肽对动脉粥样硬化形成过程中脂质过氧化的影响 被引量:3

Effect of pituitary adenylate cyclase-activating polypeptide on lipoperoxidation during rabbits atherosclerosis development
下载PDF
导出
摘要 目的 探讨垂体腺苷酸环化酶激活肽 (PACAP)对家兔实验性动脉粥样硬化 (AS)形成过程中脂质过氧化的影响。方法  80只雄性新西兰家兔 ,随机分为 3组 :(1)对照组 (C组 ) :喂饲普通颗粒兔饲料 ;(2 )AS模型组 :每只兔每日喂饲含胆固醇 1 5g的颗粒兔饲料 ;(3)PACAP组 (P组 ) :喂饲与AS组同样的饲料 ,另从耳缘静脉注射PACAP。分别于实验的 0、4、8、12周末记录兔体重 ,同时从兔耳中央动脉取空腹血 ,测定丙二醛 (MDA)含量 :并取若干兔的主动脉标本作苏丹Ⅳ染色 ,测量斑块面积。结果  (1)AS组及P组血清MDA含量均显著高于C组 ;而P组显著低于AS组。 (2 ) 4周末时P组斑块面积显著小于AS组。结论 PACAP具有抗脂质过氧化作用 。 Objective To investigate the anti lipoperoxidation effect of pituitary adenylate cyclase activating polypeptide(PACAP) in atherosclerotic rabbits.Methods Eighty male rabbits were divided into three groups randomly,control group(C group)received normal feed,AS group received the feed with 1.5g cholesterol every day,PACAP group(P group)received high lipid forage adding PACAP injection.The weight of rabbits was recored at the end of week 0,week 4,week 8 and week 12,meanwhile the concentration of serum malonyldialdehyde(MDA)was measured.Sundan Ⅳ stain was used to show the relative area of atherosclerotic plaque.Results (1)Serum MDA level of AS group and P group was obviously higher than that of C group,there was a significant difference between AS group and P group.(2)The plaque area of P group was smaller than that of As group at the end of week 4.Conclusion PACAP has good effect against lipoperoxidation which maybe relates to antiatherogenesis.
出处 《解剖学研究》 CAS 2002年第1期28-29,共2页 Anatomy Research
基金 国家自然科学基金资助课题 (No .3 980 0 0 68)
关键词 动脉粥样硬化 垂体腺苷酸环化酶激活肽 丙二醛 脂质过氧化 Atherosclerosis Pituitary adenylate cyclase activating polypeptide Malonyldialdehyde lipoperoxidation
  • 相关文献

参考文献6

二级参考文献16

  • 1吴伟康,尧宏斌,侯灿,罗汉川.四逆汤保护缺血心肌功能的实验研究[J].中国中医基础医学杂志,1995,1(3):24-26. 被引量:30
  • 2毛平,王辨明.高压液相色谱荧光法法测定人纤维蛋白肽A,Bβ...[J].中华血液学杂志,1989,10(9):466-468. 被引量:1
  • 3常青 邓漪平.神经肽PACAP保护内皮细胞拮抗低密度脂蛋白损伤的研究[J].中国病理生理杂志,1996,12:743-743.
  • 4王绪义,中华医学检验杂志,1989年,12卷,3期,163页
  • 5齐夙菊,第一军医大学学报,1986年,6卷,2期,152页
  • 6张华林,生物化学与生物物理学报,1989年,21卷,257页
  • 7蔡武城,生物物质常用化学分析法,1982年,148页
  • 8田庆印,山东医药,1996年,36卷,14页
  • 9王国平,中华病理学杂志,1996年,25卷,220页
  • 10常青,中国病理生理杂志,1996年,12卷,743页

共引文献142

同被引文献29

  • 1张莉,常青.血管内皮功能与血管重塑[J].中国循环杂志,2004,19(4):317-320. 被引量:9
  • 2李刚,刘运俊,石磊.慢性心力衰竭患者心房结构心电重塑与心律失常[J].中国老年学杂志,2005,25(2):134-135. 被引量:6
  • 3张莉,常青,李自成,黄华梅,唐海兰,关洁宾.动脉粥样硬化形成过程中内皮功能的变化及垂体腺苷酸环化酶激活肽的干预作用[J].临床心血管病杂志,2005,21(4):227-229. 被引量:8
  • 4Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s.Nature,1993,362 :801-809.
  • 5Russo G,Leopold J A,Loscalzo J.Vasoactive substance:Nitric oxide and endothelial dysfunction in athero-sclerosis. Vasc Pharmacol,2002,38:259- 269.
  • 6Kawashima S,Yokoyama M.Dysfunction of Endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol,2004,24:998-1005.
  • 7Vaudry D,Gonzalez BJ,Basille M,et al. Pituitary Adenylate Cyclase-Activating Polypeptide and its receptors:from structure to functions. Pharmacological Reviews,2000,52 (2): 269-324
  • 8Pasterkamp G,de Kleijin DPV,Borst C. Arterial remodeling in atherosclerosis,restenosis and after alteration of blood flow:potential mechanisms and clinical implications. Cardiovasc Res,2000,45(4): 843-852
  • 9Herity NA,Ward MR,Lo S,et al. Review:Clinical aspects of vascular remodeling. J Cardiovasc Electrophysiol,1999,10 (7): 1 016-024
  • 10Gibbons GH,Dzau VJ. The emerging concept of vascular remodeling. Mechanisms of Disease,1994,330 (20): 1 431-438

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部